Brown-Forman is upgraded to Buy as its current valuation offers a solid margin of safety for a resilient, high-quality business. BF's stable cash flow and improved margins underscore robust capital allocation and operational strength, despite flat sales and macro headwinds. Management expects FY27 net sales to remain flat and organic operating income to decline 3–5%, but CAPEX will also drop significantly, supporting ongoing cost-saving initiatives.